We are live on ! Find out more
RGC

Roberts, Glore & Co Portfolio holdings

AUM $364M
1-Year Est. Return 19.54%
This Fund
S&P 500
This Quarter Est. Return
-2.49%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$303M
AUM Growth
-$9.88M
Cap. Flow
+$108K
Cap. Flow %
0.04%
Top 10 Hldgs %
36.91%
Holding
202
New
2
Increased
40
Reduced
95
Closed
4
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEF icon
26
Sprott Physical Gold and Silver Trust
CEF
$7.39B
$2.59M 0.86%
149,621
+600
+0.4% +$10.9K
WMT icon
27
Walmart Inc
WMT
$888B
$2.51M 0.83%
47,073
-315
-0.7% -$16.8K
NSC icon
28
Norfolk Southern
NSC
$75.4B
$2.4M 0.79%
12,176
-250
-2% -$54K
VCSH icon
29
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$2.36M 0.78%
31,401
+4,402
+16% +$332K
ATRI
30
DELISTED
Atrion Corp
ATRI
$2.3M 0.76%
5,575
-55
-1% -$27.6K
PG icon
31
Procter & Gamble
PG
$335B
$2.29M 0.76%
15,732
-185
-1% -$28.3K
AMGN icon
32
Amgen
AMGN
$207B
$2.28M 0.75%
8,495
-25
-0.3% -$6.24K
LIN icon
33
Linde
LIN
$221B
$2.28M 0.75%
6,116
-395
-6% -$150K
BDX icon
34
Becton Dickinson
BDX
$45.4B
$2.22M 0.73%
8,592
ANET icon
35
Arista Networks
ANET
$225B
$2.22M 0.73%
48,300
-3,400
-7% -$151K
RTX icon
36
RTX Corp
RTX
$289B
$2.07M 0.68%
28,696
+1,996
+7% +$171K
VBR icon
37
Vanguard Morningstar Small-Cap Value ETF
VBR
$37.1B
$2.06M 0.68%
12,945
+37
+0.3% +$6.19K
CNC icon
38
Centene
CNC
$30.6B
$2.04M 0.68%
29,659
+1,190
+4% +$79.2K
MGV icon
39
Vanguard Morningstar Mega Cap Value ETF
MGV
$13.2B
$2.03M 0.67%
20,055
-214
-1% -$22.4K
CVS icon
40
CVS Health
CVS
$134B
$1.98M 0.65%
28,391
+1,745
+7% +$124K
UNP icon
41
Union Pacific
UNP
$174B
$1.93M 0.64%
9,490
-75
-0.8% -$16.3K
VIG icon
42
Vanguard Dividend Appreciation ETF
VIG
$111B
$1.91M 0.63%
12,323
-61
-0.5% -$9.89K
DGX icon
43
Quest Diagnostics
DGX
$25.9B
$1.89M 0.63%
15,539
VRTX icon
44
Vertex Pharmaceuticals
VRTX
$120B
$1.79M 0.59%
5,138
-14
-0.3% -$4.9K
TECH icon
45
Bio-Techne
TECH
$11.2B
$1.78M 0.59%
26,108
-18
-0.1% -$1.42K
BAB icon
46
Invesco Taxable Municipal Bond ETF
BAB
$1.02B
$1.78M 0.59%
70,201
+7,700
+12% +$200K
NVS icon
47
Novartis
NVS
$297B
$1.7M 0.56%
16,676
-250
-1% -$25.4K
MTB icon
48
M&T Bank
MTB
$35.9B
$1.63M 0.54%
12,856
-158
-1% -$20.6K
META icon
49
Meta Platforms (Facebook)
META
$1.39T
$1.6M 0.53%
5,338
-649
-11% -$196K
CME icon
50
CME Group
CME
$96.7B
$1.6M 0.53%
8,001

Similar funds

Roberts, Glore & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Roberts, Glore & Co held 202 positions worth $303M, down 3.2% from $313M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3%. Roberts, Glore & Co opened 2 new positions and exited 4, leaving the 202-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 20% a quarter earlier, followed by Technology and Financials.

  • Roberts, Glore & Co's largest Q3 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 7,274 shares worth $536K.
  • Roberts, Glore & Co added most to Vanguard Short-Term Inflation-Protected Securities Index Fund in Q3 2023, an estimated $1.46M increase.
  • Roberts, Glore & Co's biggest Q3 2023 reduction was Berkshire Hathaway Class B, cutting an estimated $717K.
  • Roberts, Glore & Co fully exited iShares TIPS Bond ETF in Q3 2023, selling an estimated $243K.
  • Roberts, Glore & Co's ten largest holdings make up 37% of its $303M portfolio in Q3 2023.
  • Roberts, Glore & Co opened 2 new positions and closed 4 in Q3 2023.
  • Roberts, Glore & Co's portfolio value fell 3.2% quarter-over-quarter to $303M.

Based on Roberts, Glore & Co's 13F filing for Q3 2023, filed 13 Nov 2023.